Peter Westervelt
Overview
Explore the profile of Peter Westervelt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
10954
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abboud R, Schroeder M, Rettig M, Jayasinghe R, Gao F, Eisele J, et al.
Blood
. 2024 Nov;
PMID: 39576962
Haploidentical hematopoietic cell transplantation (haplo-HCT) is an increasingly used treatment for hematologic malignancies. Although post-transplant cyclophosphamide (PtCy) has improved graft vs. host disease (GvHD) prophylaxis in haplo-HCT, patients continue to...
2.
Dehn J, Logan B, Shaw B, Devine S, Ciurea S, Horowitz M, et al.
medRxiv
. 2024 Oct;
PMID: 39371123
Importance: Patients requiring allogeneic hematopoietic cell transplantation have variable likelihoods of identifying an 8/8 HLA-matched unrelated donor. A Search Prognosis calculator can estimate the likelihood. Objective: To determine if using...
3.
Jacoby M, Duncavage E, Khanna A, Chang G, Nonavinkere Srivatsan S, Miller C, et al.
Leukemia
. 2024 Oct;
39(1):166-177.
PMID: 39367170
Accurate assessment of therapy response in myelodysplastic neoplasm (MDS) has been challenging. Directly monitoring mutational disease burden may be useful, but is not currently included in MDS response criteria, and...
4.
Hill J, Martens M, Young J, Bhavsar K, Kou J, Chen M, et al.
Clin Infect Dis
. 2024 May;
79(2):542-554.
PMID: 38801746
Background: The optimal timing of vaccination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines after cellular therapy is incompletely understood. The objectives of this study are to determine whether...
5.
Hill J, Martens M, Young J, Bhavsar K, Kou J, Chen M, et al.
medRxiv
. 2024 Feb;
PMID: 38343800
Background: The optimal timing of vaccination with SARS-CoV-2 vaccines after cellular therapy is incompletely understood. Objective: To describe humoral and cellular responses after SARS-CoV-2 vaccination initiated <4 months versus 4-12...
6.
Saber W, Bansal A, Li L, Scott B, Sangaralingham L, Thao V, et al.
JCO Oncol Pract
. 2024 Jan;
20(4):572-580.
PMID: 38261970
Purpose: BMT CTN 1102 was a phase III trial comparing reduced-intensity allogeneic hematopoietic cell transplantation (RIC alloHCT) to standard of care for persons with intermediate- or high-risk myelodysplastic syndrome (MDS)....
7.
McCarthy P, Attwood K, Liu X, Chen G, Minderman H, Alousi A, et al.
Bone Marrow Transplant
. 2023 Dec;
59(3):334-343.
PMID: 38110620
Identifying plasma biomarkers early after allo-HCT may become crucial to prevent and treat severe aGvHD. We utilized samples from 203 allo-HCT patients selected from the Blood & Marrow Transplant Clinical...
8.
Ghobadi A, Foley N, Cohen J, Rettig M, Cashen A, Gehrs L, et al.
Blood Adv
. 2023 Oct;
8(3):513-522.
PMID: 37871306
Outcomes in patients with relapsed diffuse large B-cell lymphoma (DLBCL) who undergo autologous stem cell transplant (auto-SCT) are poor. Blinatumomab is a CD3/CD19 bispecific T-cell engager that directs cytotoxic T...
9.
Versluis J, Saber W, Tsai H, Gibson C, Dillon L, Mishra A, et al.
J Clin Oncol
. 2023 Aug;
41(28):4497-4510.
PMID: 37607457
Purpose: Allogeneic hematopoietic cell transplantation (HCT) in patients with myelodysplastic syndrome (MDS) improves overall survival (OS). We evaluated the impact of MDS genetics on the benefit of HCT in a...
10.
Xu Z, Choi J, Cooper M, King J, Fiala M, Liu J, et al.
Transplant Cell Ther
. 2023 Aug;
29(11):699.e1-699.e9.
PMID: 37597685
Graft-versus-host disease (GVHD) is a major complication after allogeneic hematopoietic cell transplantation (allo-HCT). The hypomethylating agent azacitidine (AZA) has been shown to be effective in preclinical and clinical studies for...